Trial intelligence / Profile preview

TAPISTRY phase II precision immunotherapy and targeted therapy basket trial in solid tumors

CTR20210680Phase 2Active

Sponsor
Roche
Start
Sep 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of alectinib in Nonhematologic neoplasms, sponsored by Roche. Started Sep 2021; status: active.

02

Drugs

alectinib
03

Conditions

Nonhematologic neoplasms

Beyond the preview

Go deeper on CTR20210680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20210680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call